Jump to content
Health NZ Taranaki Lab Manual

Carcinoembryonic Antigen

Department
Biochemistry
Revision as of 11:56, 20 January 2025 by Kasey Ali Glennie (Kgl005) (talk | contribs) (Created page with "{{DISPLAYTITLE: Carcinoembryonic Antigen}} Full Test List Biochemistry Tests {| class="wikitable" ! colspan="2" | ===''Overview''=== |- |Department |Biochemistry |- |Test Code |TCEA |- |Synonyms |CEA  |- |Turnaround Time |2 hours – 3 days |- |Stability – Add test |24 hours  |- ! colspan="2" | ===''Specimen Requirements''=== |- |Specimen Type |6 mL <span style="background:#e30022"> red top </span> or <span style="background: #fbec5d"> yellow top</span>...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Tests:Carcinoembryonic Antigen


Overview

Department Biochemistry
Test Code TCEA
Synonyms CEA 
Turnaround Time 2 hours – 3 days
Stability – Add test 24 hours 

Specimen Requirements

Specimen Type 6 mL red top or yellow top  
Specimen Transportation
Preferred
Acceptable
Pediatric Requirements Minimum 0.5 mL blood in 6 mL Plain red-top 

Aliquot Requirements

Sample Type
Minimum Volume 100 uL 
Aliquot Transportation

Clinical Information

Reference Intervals 0.0 - 5.0 ug/L 
Test Method Abbott Alinity Ci using Abbott reagents. 
Advanced Notice Not Required  
Patient Preparation Not Required  

Comments

CEA is a marker for colorectal, gastrointestinal, lung and breast carcinomas. 

CEA levels are not an absolute test for evidence of malignancy and must be used in conjunction with the clinical evaluation of the patient and other diagnostic evidence.

Healthy non-smokers have CEA levels less than 3.0 µg/mL, while 6% of otherwise healthy smokers have CEA levels up to 5.0 µg/mL. 

CEA is not suitable as a screening test for the primary diagnosis of tumours.

For the serial monitoring of tumours, tumour markers should be tested in the same laboratory.